*ST Longjin: Progress Announcement on the Use of Idle Own Funds for Cash Management
*ST Longjin: Announcement on the Notice of Approval of the Application for Drug Supplementation for Febustel Tablets
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
*ST Longjin: Risk Warning Notice Regarding the Possible Termination of the Company\'s Stock Listing
*ST Longjin: Risk Warning Notice Regarding the Possible Termination of the Company\'s Stock Listing
*ST Longjin: Risk Warning Notice Regarding the Possible Termination of the Company\'s Stock Listing
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
*ST Longjin: Risk Warning Notice Regarding the Possible Termination of the Company\'s Stock Listing
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
*ST Longjin: Risk Warning Notice Regarding the Possible Termination of the Company\'s Stock Listing
*ST Longjin: Announcement on Accrued Asset Impairment Preparation and Credit Impairment Preparation
*ST Longjin: 2024 performance forecast
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
*ST Longjin: Risk Warning Notice Regarding the Possible Termination of the Company\'s Stock Listing
*ST Longjin: Rules of Procedure for the Board of Directors (revised in December 2024)
*ST Longjin: Announcement on completing the filing of regulations and issuing a business license
*ST Longjin: Announcement on Abnormal Fluctuations in Stock Trading
*ST Longjin: Articles of Association (revised in December 2024)
*ST Longjin: Rules of Procedure for Shareholders\' Meeting (Revised in December 2024)
*ST Longjin: Supervisory Board Rules of Procedure (revised in December 2024)